Coffee consumption and risk of colorectal cancer: A systematic review and meta-analysis of prospective cohort studies

International Journal of Cancer

Volumn 124, Issue 7, 2009, Pages 1662-1668

  Je, Youjin ^a   Liu, Wei ^a   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Caffeine; Coffee; Colorectal neoplasms; Meta analysis; Prospective studies

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RISK; CLINICAL TRIAL; COFFEE; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EUROPE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; JAPANESE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING CESSATION; SYSTEMATIC REVIEW; COLORECTAL TUMOR; FEMALE; MALE; RISK FACTOR;

COFFEE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 61449253081     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24124     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 1999;15:523-6.
3. Tavani A, La Vecchia C. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Control 2004;15:743-57.
4. Nehlig A, Debry G. Potential genotoxic, mutagenic and anti-mutagenic effects of coffee: a review. Mutat Res 1994;317:145-62.
5. Porta M, Vioque J, Ayude D, Alguacil J, Jariod M, Ruiz L, Murillol JA. Coffee drinking: the rationale for treating it as a potential effect modifier of carcinogenic exposures. Eur J Epidemiol 2003;18:289-98.
6. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol 1998;147:1043-52.
7. Michels KB, Willett WC, Fuchs CS, Giovannucci E. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer J Natl Cancer Inst 2005;97:282-92.
8. Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D. Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutr Cancer 1998;31:41-8.
9. Terry P, Bergkvist L, Holmberg L, Wolk A. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Swedish women. Gut 2001;49:87-90.
10. Larsson SC, Bergkvist L, Giovannucci E, Wolk A. Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 2006;163:638-44.
11. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett 2006;244:260-7.
12. Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Matsuda-Ohmori K, Shimazu T, Fukao A, Tsuji I. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 2007;120:1542-7.
13. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S; JPHC Study Group. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 2007;121:1312-8
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
15. Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986;76:823-31.
16. Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA. The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol 1988;128:1007-15.
17. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Control 1994;5:401-8.
18. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity, and other risk factors for colorectal cancer: a prospective study. Br J Cancer 1987;55:687-94.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
20. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-63.
24. Sterne JAC, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.
25. Phillips RL, Snowdon DA. Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst 1985;74:307-17.
26. Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut 1990;31:450-3.
27. Shimizu H, Ohwaki A, Kurisu Y, Takatsuka N, Ido M, Kawakami N, Nagata C, Inaba S. Validity and reproducibility of a quantitative food frequency questionnaire for a cohort study in Japan. Jpn J Clin Oncol 1999;29:38-44.
28. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18:858-67.
29. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
30. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, Shibuya D, Tsuji I. Coffee consumption and risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005;116:150-4.
31. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County. California. Cancer Control 1992;3:457-73.
32. Tavani A, Pregnolato A, La Vecchia C, Negri E, Talamini R, Franceschi S. Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3,530 cases and 7,057 controls. Int J Cancer 1997;73:193-7.
33. Slattery ML, Caan BJ, Anderson KE, Potter JD. Intake of fluids and methylxanthine-containing beverages: association with colon cancer. Int J Cancer 1999;81:199-204.
34. Bracken MB, Triche E, Grosso L, Hellenbrand K, Belanger K, Leaderer BP. Heterogeneity in assessing self-reports of caffeine exposure: implications forstudies ofhealtheffects. Epidemiology 2002;13:165-71.
35. George SE, Ramalakshmi K, Mohan Rao LJ. A perception on health benefits of coffee. Crit Rev Food Sci Nutr 2008;48:464-86.
36. Slattery ML, West DW, Robison LM, French TK, Ford MH, Schuman KL, Sorenson AW. Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population. Epidemiology 1990;1:141-5.
37. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31:925-43.
38. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willet W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990;323:1026-32.
39. Nomura A, Heilbrun LK, Stemmermann GN. Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 1986;76:587-90.
40. Gerhardsson M, Floderus B, Norell SE. Physical activity and colon cancer risk. Int J Epidemiol 1988;17:743-6.
41. Suadicani P, Hein HO, Gyntelberg F. Height, weight, and risk of colorectal cancer. an 18-year follow-up in a cohort of 5249 men. Scand J Gastroenterol 1993;28:285-8
42. Kato TS, Takahashi S, Kikugawa K. Loss of heterocyclic amine muta-gens by insoluble hemicelluloses fiber and high molecular-weight soluble polyphenolics of coffee. MutatRes 1991;246:169-78.
43. Daglia M, Papetti A Gregotti C, Berte F, Gazzani G. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J Agric Food Chem 2000;48:1449-54.
44. Anese M, Nicoli MC. Antioxidant properties of ready-to-drink coffee brews. J Agric Food Chem 2003;51:942-6.
45. Potter JD. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA 1991;268:1573-7.
46. Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Muller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol 2007;21:1603-16.
47. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002;40:1155-63.
48. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systemic review. JAMA 2005;294:97-104.
49. Wu T, Willett WC, Hankinson SE, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005;28:1390-6.